IFN α -mediated remodeling of endothelial cells in the bone marrow niche

Haematologica

Volumn 102, Issue 3, 2017, Pages 445-453

  Prendergast, Áine M ^a   Kuck, Andrea ^a   van Essen, Mieke ^a   Haas, Simon ^a   Blaszkiewicz, Sandra ^a   Essers, Marieke A G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEVACIZUMAB; CELL ADHESION MOLECULE; EVANS BLUE; LAMININ; PHOSPHATE BUFFERED SALINE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; BIOLOGICAL MARKER; POLYINOSINIC POLYCYTIDYLIC ACID; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BONE MARROW; BONE MARROW TRANSPLANTATION; BRDU ASSAY; CELL ACTIVATION; CELL ISOLATION; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULARIZATION; ANGIOGENESIS; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BONE MARROW CELL; CAPILLARY PERMEABILITY; CYTOLOGY; DRUG EFFECTS; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; METABOLISM; PHENOTYPE; PHYSIOLOGICAL STRESS; STEM CELL NICHE; TUMOR MICROENVIRONMENT;

ANIMALS; BIOMARKERS; BONE MARROW; BONE MARROW CELLS; CAPILLARY PERMEABILITY; CELL PROLIFERATION; CELLULAR MICROENVIRONMENT; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; POLY I-C; SIGNAL TRANSDUCTION; STEM CELL NICHE; STRESS, PHYSIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85014448615     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2016.151209     Document Type: Article

References (48)

1. Orozco AS, Zhou X, Filler SG. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect Immun. 2000;68(3):1134-1141.
2. Bazzoni G, Dejana E. Endothelial cell-tocell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84(3):869-901.
3. Pober JS. Endothelial activation: intracellular signaling pathways. Arthritis Res. 2002; 4(Suppl 3):S109-16.
4. Granger DN, Rodrigues SF, Yildirim A, Senchenkova EY. Microvascular responses to cardiovascular risk factors. Microcirculation. 2010;17(3):192-205.
5. Muller WA. Getting leukocytes to the site of inflammation. Vet Pathol. 2013;50(1):7-22.
6. Jones N, Iljin K, Dumont DJ, Alitalo K. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol. 2001;2(4):257-267.
7. Itkin T, Gur-Cohen S, Spencer JA, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532(7599):323-328.
8. Kusumbe AP, Ramasamy SK, Itkin T, et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature. 2016;532(7599):380-384.
9. Cardier JE, Barbera-Guillem E. Extramedullary hematopoiesis in the adult mouse liver is associated with specific hepatic sinusoidal endothelial cells. Hepatology. 1997;26(1):165-175.
10. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012;481(7382):457-462.
11. Gattazzo F, Urciuolo A, Bonaldo P. Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim Biophys Acta. 2014;1840(8):2506-2519.
12. Li W, Johnson SA, Shelley WC, Yoder MC. Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp Hematol. 2004; 32(12):1226-1237.
13. Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327-334.
14. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10(1):64-71.
15. Zhao YD, Huang X, Yi F, et al. Endothelial FoxM1 mediates bone marrow progenitor cell-induced vascular repair and resolution of inflammation following inflammatory lung injury. Stem Cells. 2014;32(7):1855-1864.
16. Essers MA, Offner S, Blanco-Bose WE, et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature. 2009;458(7240):904-908.
17. Muller U, Steinhoff U, Reis LF, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994; 264(5167):1918-1921.
18. Kunisaki Y, Bruns I, Scheiermann C, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013; 502(7473):637-643.
19. Radu M, Chernoff J. An in vivo assay to test blood vessel permeability. J Vis Exp. 2013;73:e50062.
20. Haas S, Hansson J, Klimmeck D, et al. Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors. Cell Stem Cell. 2015;17(4):422-434.
21. Kawamoto T. Use of a new adhesive film for the preparation of multi-purpose freshfrozen sections from hard tissues, wholeanimals, insects and plants. Arch Histol Cytol. 2003;66(2):123-143.
22. Bentley K, Franco CA, Philippides A, et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol. 2014;16(4):309-321.
23. Pietras EM, Lakshminarasimhan R, Techner JM, et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med. 2014;211(2):245-262.
24. Wada H, Nagano H, Yamamoto H, et al. Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells. BMC Cancer. 2009;9:361.
25. Sgonc R, Fuerhapter C, Boeck G, Swerlick R, Fritsch P, Sepp N. Induction of apoptosis in human dermal microvascular endothelial cells and infantile hemangiomas by interferon-alpha. Int Arch Allergy Immunol. 1998;117(3):209-214.
26. Reynolds JA, Ray DW, Zeef LA, O’Neill T, Bruce IN, Alexander MY. The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus. J Interferon Cytokine Res. 2014;34(5):404-412.
27. Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, Tschachler E. Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation. Lab Invest. 2006;86(10):997-1007.
28. Cheng X, Liu Y, Chu H, Kao HY. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor alpha (TNFalpha) and interferon alpha (IFNalpha). J Biol Chem. 2012; 287(28):23356-23367.
29. Lee S, Chen TT, Barber CL, et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007;130(4):691-703.
30. Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol. 2012;590(Pt 5):1023-1034.
31. Bruns I, Lucas D, Pinho S, et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med. 2014;20(11):1315-1320.
32. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009; 22(2):240-273, Table of Contents.
33. Rajendran P, Rengarajan T, Thangavel J, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9(10):1057-1069.
34. Borden EC, Sen GC, Uze G, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975-990.
35. Essers MA, Trumpp A. Targeting leukemic stem cells by breaking their dormancy. Mol Oncol. 2010;4(5):443-450.
36. Rosa R, Monteleone F, Zambrano N, Bianco R. In vitro and in vivo models for analysis of resistance to anticancer molecular therapies. Curr Med Chem. 2014; 21(14):1595-1606.
37. Bauer EM, Zheng H, Lotze MT, Bauer PM. Recombinant human interferon alpha 2b prevents and reverses experimental pulmonary hypertension. PLoS One. 2014; 9(5):e96720.
38. Merkle M, Ribeiro A, Belling F, et al. Response of VEGF to activation of viral receptors and TNFalpha in human mesangial cells. Mol Cell Biochem. 2012;370(1-2):151-161.
39. von Marschall Z, Scholz A, Cramer T, et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst. 2003;95(6):437-448.
40. Gambara G, Desideri M, Stoppacciaro A, et al. TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo. J Cell Mol Med. 2015; 19(2):327-339.
41. Raig ET, Jones NB, Varker KA, et al. VEGF secretion is inhibited by interferon-alpha in several melanoma cell lines. J Interferon Cytokine Res. 2008;28(9):553-561.
42. Boulais PE, Frenette PS. Making sense of hematopoietic stem cell niches. Blood. 2015;125(17):2621-2629.
43. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature. 2013;495(7440):231-235.
44. Kunisaki Y, Frenette PS. Influences of vascular niches on hematopoietic stem cell fate. Int J Hematol. 2014;99(6):699-705.
45. Lamagna C, Bergers G. The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol. 2006;80(4):677-681.
46. Quillard T, Charreau B. Impact of notch signaling on inflammatory responses in cardiovascular disorders. Int J Mol Sci. 2013; 14(4):6863-6888.
47. Ribatti D, Vacca A, De Falco G, Ria R, Roncali L, Dammacco F. Role of hematopoietic growth factors in angiogenesis. Acta Haematol. 2001;106(4):157-161.
48. Ribatti D, Vacca A, Roncali L, Dammacco F. Hematopoiesis and angiogenesis: a link between two apparently independent processes. J Hematother Stem Cell Res. 2000;9(1):13-19.